AUG 17, 2016 07:15 PM PDT

Redefining A Cell's Identity with Gene Editing

WRITTEN BY: Kara Marker
Just a couple of miles down the road from North Carolina State University where CRISPR pioneer Rodolphe Barrangou, PhD, has his lab, scientists at Duke University are modifying the genetic modifying technique to directly activate existing gene copies in the genome rather than adding additional copies. The result? A complete reprogramming of a cell’s identity.
Charles Gersbach, director for the Center of Biomolecular and Tissue Engineering at Duke University
In the past, scientists have used viruses, injected into the genome, to introduce extra copies of certain genes to produce a large number of “master transcription factors” in order to induce a permanent change in the cell’s gene network. However, after realizing that a temporary signal that could change the cell type to reach a stable destination would be more effective than making irreversible changes, the research group from Duke decided to tweak current CRISPR technology to create a temporary signal.

In their study, the researchers used a “splice-less” version of CRISPR to identify specific regions of DNA and attach them to a gene activator to activate exactly three genes. (For more about CRISPR gene editing technology, click here.) The three genes they activated naturally produce the master transcription factors in the cell’s genome responsible for controlling the neuronal gene network. Activating the network in this manner created newly-converted neuronal cells with a more complete and persistent conversion profile than with techniques using viruses.

Using this version of CRISPR technology to convert isolated mouse connective tissue cells directly into neuronal cells could be applied to modeling neurological disorders, discovering new therapeutics, developing personalized medicines, and even implementing cell therapy, researchers report. Duke scientist Charles Gersbach provides an example: 

“We might have a general idea of how most people's neurons will respond to a drug, but we don't know how your particular neurons with your particular genetics will respond. If we could take a skin cell from your arm, turn it into a neuron, and then treat it with various drug combinations, we could determine an optimal personalized therapy."

The experimental method in this study pose a challenge to scientists: producing stable neuronal cells efficiently while also ensuring their genome looks like a “real” neuron. In the future, Duke scientists plan to apply this technology to isolated human cells as well as improve the technique’s efficiency and apply it to model particular diseases.

This study was recently published in the journal Cell Stem Cell.
 


Source: Duke University
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 20, 2019
Cell & Molecular Biology
OCT 20, 2019
The Rise of Drug Resistance Among Malaria Parasites
Around 220 million people get malaria every year after being bitten by a mosquito infected with the parasite that causes the disease....
OCT 20, 2019
Genetics & Genomics
OCT 20, 2019
Invasive Tumbleweed Demonstrates the Advantage of Extra Chromosomes
The massive tumbleweed Salsola ryanii was once thought to be going extinct, but it's growing stronger....
OCT 20, 2019
Genetics & Genomics
OCT 20, 2019
Wild Wheat Genes are the Answer to Climate Change Food Shortage
By 2050, the UN has estimated that wheat production needs to increase by 60% in order to feed the world’s population, estimated to reach around 9.6 b...
OCT 20, 2019
Neuroscience
OCT 20, 2019
Can CRISPR Technology Treat Alzheimer's?
New drugs that seek to treat Alzheimer’s disease (AD) have a 99.6% failure rate. This makes it the only disease in the top 10 causes of death that ca...
OCT 20, 2019
Genetics & Genomics
OCT 20, 2019
A 'Molecular Clock' for Determining a Child's Age
This tool can aid in the diagnosis of developmental disorders, including autism spectrum disorder....
OCT 20, 2019
Neuroscience
OCT 20, 2019
Autism May be Linked to an Immune Disorder
Until now, diagnosis for autism spectrum disorder have relied on behavioral assessments looking for symptoms including poor social and communication skills...
Loading Comments...